Gates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingGates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement

Cellscript – BioNTech mRNA Technology Patent Sublicense

• Post author:GHIAA Admin
• Post published:March 17, 2022
• Post category:

Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense

Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

• Post author:GHIAA Admin
• Post published:December 21, 2021
• Post category:

Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement

Merck – MPP, Molnupiravir License Agreement

• Post author:GHIAA Admin
• Post published:November 19, 2021
• Post category:

Continue ReadingMerck – MPP, Molnupiravir License Agreement

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

• Post author:GHIAA Admin
• Post published:June 30, 2021
• Post category:

Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

CEPI CfP3i Template Funding Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingCEPI CfP3i Template Funding Agreement

IMI 1 Model Grant Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingIMI 1 Model Grant Agreement

Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

MPP – ViiV, Dolutegravir License Agreement

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue ReadingMPP – ViiV, Dolutegravir License Agreement